Efficacy and safety of tezepelumab in patients with uncontrolled disease while receiving maintenance therapy for moderate or severe asthma

By sjmartinez • March 14, 2023

Corren J, Wechsler ME, Chupp G, Roseti SL, Hellqvist Å, Martin N, Llanos JP, Ambrose CS, Colice G. Efficacy and safety of tezepelumab in patients with uncontrolled disease while receiving maintenance therapy for moderate or severe asthma. J Allergy Clin Immunol Pract. 2023 Mar;11(3):943-945.e2. doi: 10.1016/j.jaip.2022.10.042. Epub 2022 Nov 11. PMID: 36375743.

Tags: Allergy & Immunology, Publications

Delayed Hypersensitivity to Iodinated Contrast: A Rare Case of Iododerma and Successful Strategy for Readministration

Truong T, Tsai M, Ahn TS, Anderson L. Delayed Hypersensitivity to Iodinated Contrast: A Rare Case of Iododerma and Successful Strategy for Readministration. Cureus. 2026[...]

A Cautionary Tale: Urticaria and Angioedema As Presenting Signs of Lymphoproliferative Disorders

Kafashzadeh D, Kachru R. A Cautionary Tale: Urticaria and Angioedema As Presenting Signs of Lymphoproliferative Disorders. Cureus. 2026 Apr 9;18(4):e106738. doi: 10.7759/cureus.106738. PMID: 42109948; PMCID:[...]

FRONTIER-3: a randomised phase 2a study to investigate tozorakimab, an anti-interleukin-33 monoclonal antibody, in early-onset asthma

Corren J, Reid F, Moate R, Jimenez E, Sadiq MW, Williams A, Rytelewski M, Cameron-Christie S, Muthas D, Georgi B, Brooks D, Lindqvist E, Kell[...]